Stomach cancer vaccine gets $250K injection

Research being done at Sudbury’s Advanced Medical Research Institute of Canada (AMRIC) to develop a vaccine for a form of stomach cancer is getting $250,000 from the Northern Ontario Heritage Fund Corporation.

Sudbury MP Glenn Thibeault made the announcement today during a press conference at AMRIC, which is located on Ramsey Lake Road.

The funds will be used to further research being performed by AMRIC subsidiary Lilly Creek Vaccines Inc. to develop and test a vaccine to fight the bacteria H.pylori, which live in the digestive tract and can lead to ulcers, gastritis and stomach cancer.

“Our investments in this health-care project will help advance important research in the Sudbury area,” Thibeault said in a news release.

The vaccine research, which is being conducted in partnership with the National Research Council of Canada, aims to lead to human clinical trials in Sudbury in the next two years.

This story will be updated.